| 000 | 01781 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513025559.0 | ||
| 264 | 0 | _c19951226 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm00022a020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHutchinson, J H | |
| 245 | 0 | 0 |
_aThiopyranol[2,3,4-c,d]indoles as inhibitors of 5-lipoxygenase, 5-lipoxygenase-activating protein, and leukotriene C4 synthase. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cOct 1995 |
||
| 300 |
_a4538-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _a5-Lipoxygenase-Activating Proteins |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArachidonic Acid _xmetabolism |
| 650 | 0 | 4 |
_aBronchoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aCalcimycin _xpharmacology |
| 650 | 0 | 4 |
_aCarrier Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGlutathione Transferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHaplorhini |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xchemical synthesis |
| 650 | 0 | 4 | _aLipoxygenase Inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSeminal Vesicles _xenzymology |
| 650 | 0 | 4 | _aSheep |
| 700 | 1 | _aCharleson, S | |
| 700 | 1 | _aEvans, J F | |
| 700 | 1 | _aFalgueyret, J P | |
| 700 | 1 | _aHoogsteen, K | |
| 700 | 1 | _aJones, T R | |
| 700 | 1 | _aKargman, S | |
| 700 | 1 | _aMacdonald, D | |
| 700 | 1 | _aMcFarlane, C S | |
| 700 | 1 | _aNicholson, D W | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 38 _gno. 22 _gp. 4538-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm00022a020 _zAvailable from publisher's website |
| 999 |
_c7473052 _d7473052 |
||